Citations for
1ALCAM, PRMT1
PRMT1 regulates tumor growth and metastasis of human melanoma via targeting ALCAM.
Li L, Zhang Z, Ma T, Huo R.
Mol Med Rep 14(1):521-8. doi: 10.3892/mmr.2016.5273. Epub 2016 May 13. 2016
2ALCAM, LGALS8
Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.
Fernández MM, Ferragut F, Cárdenas Delgado VM, Bracalente C, Bravo AI, Cagnoni AJ, Nuñez M, Morosi LG, Quinta HR, Espelt MV, Troncoso MF, Wolfenstein-Todel C, Mariño KV, Malchiodi EL, Rabinovich GA, Elola MT.
Biochim Biophys Acta 1860(10):2255-68. doi: 10.1016/j.bbagen.2016.04.019. Epub 2016 Apr 26. 2016
3ALCAM, CD6
CD6 modulates thymocyte selection and peripheral T cell homeostasis.
Orta-Mascaró M, Consuegra-Fernández M, Carreras E, Roncagalli R, Carreras-Sureda A, Alvarez P, Girard L, Simões I, Martínez-Florensa M, Aranda F, Merino R, Martínez VG, Vicente R, Merino J, Sarukhan A, Malissen M, Malissen B, Lozano F.
J Exp Med 213(8):1387-97. doi: 10.1084/jem.20151785. Epub 2016 Jul 4. 2016
4ALCAM, CD6
The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.
Kofler DM, Farkas A, von Bergwelt-Baildon M, Hafler DA.
Curr Drug Targets 17(6):651-65. 2016
5ALCAM, CD6
Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.
Chappell PE, Garner LI, Yan J, Metcalfe C, Hatherley D, Johnson S, Robinson CV, Lea SM, Brown MH.
Structure 23(8):1426-36. doi: 10.1016/j.str.2015.05.019. Epub 2015 Jul 2. 2015
6ALCAM
Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis.
Hooker RA, Chitteti BR, Egan PH, Cheng YH, Himes ER, Meijome T, Srour EF, Fuchs RK, Kacena MA.
J Musculoskelet Neuronal Interact 15(1):83-94. 2015
7ALCAM, EZR, SDCBP
Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton.
Tudor C, te Riet J, Eich C, Harkes R, Smisdom N, Bouhuijzen Wenger J, Ameloot M, Holt M, Kanger JS, Figdor CG, Cambi A, Subramaniam V.
J Biol Chem 289(19):13445-60. doi: 10.1074/jbc.M113.546754. Epub 2014 Mar 24. 2014
8AKT1, ALCAM, FOXO1
CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKT.
Yu W, Wang J, Ma L, Tang X, Qiao Y, Pan Q, Yu Y, Sun F.
Oncol Rep 32(2):677-83. doi: 10.3892/or.2014.3226. Epub 2014 May 30. 2014
9ALCAM, CD6
Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6.
Te Riet J, Helenius J, Strohmeyer N, Cambi A, Figdor CG, Müller DJ.
J Cell Sci 127(Pt 7):1595-606. doi: 10.1242/jcs.141077. Epub 2014 Feb 4. 2014
10ALCAM, CD6, LGALS1, LGALS3
Modulation of CD6 function through interaction with Galectin-1 and -3.
Escoda-Ferran C, Carrasco E, Caballero-Baños M, Miró-Julià C, Martínez-Florensa M, Consuegra-Fernández M, Martínez VG, Liu FT, Lozano F.
FEBS Lett 588(17):2805-13. doi: 10.1016/j.febslet.2014.05.064. Epub 2014 Jun 16. 2014
11ALCAM, RUNX2
Hierarchical organization of osteoblasts reveals the significant role of CD166 in hematopoietic stem cell maintenance and function.
Chitteti BR, Cheng YH, Kacena MA, Srour EF.
Bone 54(1):58-67. doi: 10.1016/j.bone.2013.01.038. Epub 2013 Jan 28. 2013
12ADAM17, ALCAM, CD9
ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.
Gilsanz A, Sánchez-Martín L, Gutiérrez-López MD, Ovalle S, Machado-Pineda Y, Reyes R, Swart GW, Figdor CG, Lafuente EM, Cabañas C.
Cell Mol Life Sci 70(3):475-93. doi: 10.1007/s00018-012-1132-0. Epub 2012 Sep 30. 2013
13ALCAM
Translation of the cell adhesion molecule ALCAM in axonal growth cones - regulation and functional importance.
Thelen K, Maier B, Faber M, Albrecht C, Fischer P, Pollerberg GE.
J Cell Sci 125(Pt 4):1003-14. doi: 10.1242/jcs.096149. Epub 2012 Mar 15. 2012
14ALCAM, NGF
Activated leukocyte cell adhesion molecule modulates neurotrophin signaling.
Wade A, Thomas C, Kalmar B, Terenzio M, Garin J, Greensmith L, Schiavo G.
J Neurochem 121(4):575-86. doi: 10.1111/j.1471-4159.2012.07658.x. Epub 2012 Feb 10. 2012
15ALCAM
Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.
Piao D, Jiang T, Liu G, Wang B, Xu J, Zhu A.
Mol Biol Rep 39(1):661-8. doi: 10.1007/s11033-011-0783-5. Epub 2011 Jun 14. 2012
16ALCAM
Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes.
Rauch SJ, Rosenkranz AC, Böhm A, Meyer-Kirchrath J, Hohlfeld T, Schrör K, Rauch BH.
Vascul Pharmacol 54(3-6):93-9. doi: 10.1016/j.vph.2011.03.004. Epub 2011 Mar 31. 2011
17ALCAM
Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.
Miccichè F, Da Riva L, Fabbi M, Pilotti S, Mondellini P, Ferrini S, Canevari S, Pierotti MA, Bongarzone I.
PLoS One 6(2):e17141. doi: 10.1371/journal.pone.0017141. 2011
18ALCAM
ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer.
Hong X, Michalski CW, Kong B, Zhang W, Raggi MC, Sauliunaite D, De Oliveira T, Friess H, Kleeff J.
J Surg Oncol 101(7):564-9.PMID: 20461761 2010
19ALCAM
Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
Ihnen M, Köhler N, Kersten JF, Milde-Langosch K, Beck K, Höller S, Müller V, Witzel I, Jänicke F, Kilic E.
Dis Markers 28(2):71-8.PMID: 20364042 2010
20ALCAM
ALCAM regulates mediolateral retinotopic mapping in the superior colliculus.
Buhusi M, Demyanenko GP, Jannie KM, Dalal J, Darnell EP, Weiner JA, Maness PF.
J Neurosci 29(50):15630-41.PMID: 20016077 2009
21ALCAM
Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
van Kilsdonk JW, Wilting RH, Bergers M, van Muijen GN, Schalkwijk J, van Kempen LC, Swart GW.
Cancer Res 68(10):3671-9.PMID: 18483249 2008
22ALCAM
Activated leukocyte cell adhesion molecule: a new paradox in cancer.
Ofori-Acquah SF, King JA.
Transl Res 151(3):122-8. Epub 2007 Oct 23. Review.PMID: 18279810 2008
23ALCAM
Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis.
Davies SR, Dent C, Watkins G, King JA, Mokbel K, Jiang WG.
Oncol Rep 19(2):555-61.PMID: 18202807 2008
24ADAM17, ALCAM
The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.
Rosso O, Piazza T, Bongarzone I, Rossello A, Mezzanzanica D, Canevari S, Orengo AM, Puppo A, Ferrini S, Fabbi M.
Mol Cancer Res 5(12):1246-53.PMID: 18171982 2007
25ALCAM
Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration.
Masedunskas A, King JA, Tan F, Cochran R, Stevens T, Sviridov D, Ofori-Acquah SF.
FEBS Lett 580(11):2637-45. Epub 2006 Apr 21. 2006
26ALCAM
ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A, Matysiak W, Motyl T.
Med Sci Monit 12(8):BR263-73. Epub 2006 Jul 12. 2006
27ALCAM
Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
Ikeda K, Quertermous T.
J Biol Chem 279(53):55315-23. Epub 2004 Oct 20. 2004
28ALCAM
Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
Bowen MA, et al.
J Exp Med 181 : 2213-2220. 1995
29ALCAM
Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells.
Patel DD, et al.
J Exp Med 181 : 1563-1568. 1995
30ALCAM
Characterization of a CD6 ligand(s) expressed on human- and murine-derived cell lines and murine lymphoid tissues.
Wee SF, et al.
Cell Immunol 158 : 353-364. 1994